IDSA
Every $1 in NIH Research Funding Returns $2.56 to the U.S. Economy
Programs that are already benefiting patients, as well as future medical developments, are at risk from federal ...
APRIL 25, 2025
Can We Prevent an MDR Antimicrobial Crisis?
The Senate Health, Education, Labor & Pensions Committee held a hearing about the impact of drug-resistant ...
JULY 13, 2023
CDC Recommends Additional COVID-19 Booster for Older or Immunocompromised People
After the FDA announced its new amendments to the emergency use authorizations for the Pfizer-BioNTech and Moderna ...
APRIL 20, 2023
FDA Revokes EUA for Bamlanivimab Monotherapy for COVID-19; Still Authorized in Combination
Although the FDA revoked its EUA for bamlanivimab monotherapy, the agency said it could still be given ...
APRIL 21, 2021
IDSA PPE Recommendations: A Practical Approach to Protect HCWs
The IDSA released recommendations about using PPE for infection prevention among HCWs caring for patients with ...
JANUARY 20, 2021
Cancer Patients Face Higher Risk for Shingles
People newly diagnosed with cancer, particularly hematologic cancers, and those treated with chemotherapy have a ...
DECEMBER 26, 2018
HCV Guidance Updated for Screening and Treating Key Populations
The new recommendations emphasize the importance of testing key populations and treating virtually all patients ...
MAY 25, 2018
New Hep C Recs Target Unique Populations
Updated HCV guidelines focus on cirrhosis, other challenging patients.
MAY 12, 2016
